| Literature DB >> 31660405 |
Deborah A Williamson1, Eric P F Chow2,3, Darren Lee1, Kate Maddaford2, Michelle Sait1, Marion Easton4, Danielle Ingle1, Rebecca Wigan2, Vesna De Petra1, Benjamin P Howden1, Christopher K Fairley2,3, Marcus Y Chen2,3.
Abstract
Improved knowledge of factors that promote outbreaks of enteric pathogens among men who have sex with men (MSM) could enable targeted public health interventions. We detected enteric pathogens in 57 of 519 (11%) asymptomatic MSM, and we found that enteric pathogen detection was associated with both oroanal sex (rimming) and group sex.Entities:
Keywords: enteric pathogens; epidemiology; gastrointestinal disease; sexually transmitted infections
Year: 2019 PMID: 31660405 PMCID: PMC6798250 DOI: 10.1093/ofid/ofz326
Source DB: PubMed Journal: Open Forum Infect Dis ISSN: 2328-8957 Impact factor: 3.835
Associations Between Men Who Have Sex With Men and Enteric Pathogen Detection
| Characteristics | Detection of an Enteric Pathogen, n/N (%) | OR (95% CI) |
| Adjusted OR (95% CI) |
|
|---|---|---|---|---|---|
| Age (Years) | |||||
| 18–24 | 9/84 (10.7%) | 1 (ref) | |||
| 25–34 | 29/240 (12.1%) | 1.15 (0.52–2.53) | .737 | ||
| ≥35 | 19/195 (9.7%) | 0.90 (0.39–2.08) | .805 | ||
| HIV and PrEP Status | |||||
| HIV negative, no PrEP | 20/214 (9.3%) | 1 (ref) | |||
| HIV negative, on PrEP | 29/227 (12.8%) | 1.42 (0.78–2.60) | .254 | ||
| HIV positive | 8/78 (10.3%) | 1.11 (0.47–2.63) | .815 | ||
| Rimming in the Last 12 Months | |||||
| No | 6/142 (4.2%) | 1 (ref) | 1 (ref) | ||
| Yes | 51/363 (14.0%) | 3.71 (1.55–8.84) | .003 | 3.32 (1.38–7.97) | .007 |
| Can’t remember | 0/14 (0%) | - | - | - | - |
| Group Sex in the Last Month | |||||
| No | 35/396 (8.8%) | 1 (ref) | 1 (ref) | ||
| Yes | 22/123 (17.9%) | 2.25 (1.26–4.00) | .006 | 2.00 (1.11–3.60) | .021 |
| Used Party Drugs in the Last Month | |||||
| No | 47/451 (10.4%) | 1 (ref) | |||
| Yes | 10/68 (14.7%) | 1.48 (0.71–3.09) | .295 | ||
| Sex Overseas in the Last 12 Months | |||||
| No | 15/165 (9.1%) | 1 (ref) | |||
| Yes | 16/105 (15.2%) | 1.80 (0.85–3.81) | .126 | ||
| Unknown/Declined/Missing | 26/249 (10.4%) | 1.17 (0.60–2.27) | .653 | ||
| Pharyngeal Gonorrhea | |||||
| Negative | 50/460 (10.9%) | 1 (ref) | |||
| Positive | 3/29 (11.1%) | 0.95 (0.28–3.24) | .930 | ||
| Not tested | 4/30 (12.1%) | 1.26 (0.42–3.76) | .677 | ||
| Urethral Gonorrhea | |||||
| Negative | 51/486 (10.5%) | 1 (ref) | |||
| Positive | 1/6 (16.7%) | 1.71 (0.20–14.89) | .629 | ||
| Not tested | 5/27 (18.5%) | 1.94 (0.70–5.34) | .200 | ||
| Anorectal Gonorrhea | |||||
| Negative | 51/468 (10.9%) | 1 (ref) | |||
| Positive | 2/18 (11.1%) | 1.02 (0.23–4.57) | .977 | ||
| Not tested | 4/33 (12.1%) | 1.13 (0.38–3.34) | .828 | ||
| Pharyngeal Chlamydia | |||||
| Negative | 51/486 (10.5%) | 1 (ref) | |||
| Positive | 2/7 (28.6%) | 3.41 (0.65–18.04) | .149 | ||
| Not tested | 4/26 (15.4%) | 1.55 (0.51–4.68) | .436 | ||
| Urethral Chlamydia | |||||
| Negative | 52/475 (10.9%) | 1 (ref) | |||
| Positive | 0/17 (0%) | - | |||
| Not tested | 5/27 (18.5%) | 1.85 (0.67–5.09) | .234 | ||
| Anorectal Chlamydia | |||||
| Negative | 44/442 (10.0%) | 1 (ref) | |||
| Positive | 9/44 (20.5%) | 2.33 (1.05–5.16) | .038 | ||
| Not tested | 4/33 (12.1%) | 1.25 (0.42–3.71) | .691 |
Abbreviations: CI, confidence interval; HIV, human immunodeficiency virus; OR, odds ratio; PrEP, pre-exposure prophylaxis.